Regis Healthcare Ltd.(AU:REG)
A$5.130.00 (0.00%)
AU:REG
Regis Healthcare Ltd. financials statements
A$5.13
At close:0.00 (0.00%)
Want to see AU:REG full AI Analyst Report?
Regis Healthcare Ltd. (REG) Ratios
27 Followers
Regis Healthcare Ltd. Ratios
AU:REG's free cash flow for Q4 2026 was AU$3.88M. For the 2026 fiscal year, AU:REG's free cash flow was decreased by AU$-40.63M and operating cash flow was AU$44.51M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.08 | 0.11 | 0.06 | 0.07 | 0.03 |
| Quick Ratio | 0.08 | 0.11 | 0.06 | 0.07 | 0.02 |
| Cash Ratio | 0.07 | 0.09 | 0.04 | 0.04 | 0.00 |
| Solvency Ratio | 0.04 | 0.05 | 0.06 | 0.06 | 0.04 |
| Operating Cash Flow Ratio | 0.13 | 0.15 | 0.14 | 0.07 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 263.52 | 0.00 | 0.00 | -25.90 | 10.07 |
| Net Current Asset Value | AU$ -2.39B | AU$ -1.88B | AU$ -1.73B | AU$ -1.56B | AU$ -1.64B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.04 | 0.06 |
| Debt-to-Equity Ratio | -0.33 | -0.31 | -0.17 | 1.85 | 1.43 |
| Debt-to-Capital Ratio | -0.49 | -0.44 | -0.20 | 0.65 | 0.59 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.64 | 0.55 |
| Financial Leverage Ratio | -214.07 | -125.88 | -79.20 | 44.47 | 22.32 |
| Debt Service Coverage Ratio | 19.22 | 1.83 | 2.17 | 16.31 | 3.74 |
| Interest Coverage Ratio | 17.92 | 0.50 | -0.45 | -7.12 | -4.55 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.09 | 0.19 |
| Interest Debt Per Share | 0.02 | 0.41 | 0.32 | 0.27 | 0.40 |
| Net Debt to EBITDA | -1.58 | -0.78 | -0.32 | 0.10 | 1.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.36% | 12.27% | 4.65% | -0.49% | 0.72% |
| EBIT Margin | 3.79% | 16.54% | 6.25% | 4.27% | 2.07% |
| EBITDA Margin | 7.97% | 20.86% | 18.88% | 12.55% | 7.78% |
| Operating Profit Margin | 3.79% | 5.21% | -4.03% | -9.90% | -5.03% |
| Pretax Profit Margin | 6.23% | 6.20% | -2.77% | -5.23% | -7.69% |
| Net Profit Margin | 4.14% | 4.25% | -2.11% | -3.69% | -5.40% |
| Continuous Operations Profit Margin | 4.14% | 4.25% | -2.11% | -3.69% | -5.40% |
| Net Income Per EBT | 66.52% | 68.52% | 76.20% | 70.46% | 70.31% |
| EBT Per EBIT | 164.56% | 119.01% | 68.74% | 52.88% | 152.86% |
| Return on Assets (ROA) | 2.14% | 2.33% | -1.18% | -1.67% | -2.20% |
| Return on Equity (ROE) | -459.04% | -292.70% | 93.58% | -74.10% | -49.11% |
| Return on Capital Employed (ROCE) | 47989.62% | -1030.35% | 282.88% | -43.93% | -13.59% |
| Return on Invested Capital (ROIC) | 2448.52% | -938.04% | 230.18% | -31.54% | -9.13% |
| Return on Tangible Assets | 2.89% | 2.91% | -1.48% | -2.48% | -3.46% |
| Earnings Yield | 2.84% | 2.07% | -1.69% | -4.26% | -6.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 40.92 | 31.25 | 59.75 | 19.31 | 40.08 |
| Payables Turnover | 149.94 | 94.23 | 85.83 | 62.29 | 53.77 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 420.88 | 138.04 |
| Fixed Asset Turnover | 0.86 | 0.88 | 0.83 | 0.69 | 0.64 |
| Asset Turnover | 0.52 | 0.55 | 0.56 | 0.45 | 0.41 |
| Working Capital Turnover Ratio | -0.63 | -0.64 | -0.64 | -0.54 | -0.50 |
| Cash Conversion Cycle | 6.48 | 7.81 | 1.86 | 13.91 | 4.96 |
| Days of Sales Outstanding | 8.92 | 11.68 | 6.11 | 18.90 | 9.11 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.87 | 2.64 |
| Days of Payables Outstanding | 2.43 | 3.87 | 4.25 | 5.86 | 6.79 |
| Operating Cycle | 8.92 | 11.68 | 6.11 | 19.77 | 11.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.11 | 1.02 | 0.84 | 0.35 | 0.38 |
| Free Cash Flow Per Share | 0.64 | 0.73 | 0.62 | 0.18 | 0.22 |
| Dividend Paid and CapEx Coverage Ratio | 1.74 | 2.34 | 2.35 | 1.63 | 1.60 |
| Capital Expenditure Coverage Ratio | 2.37 | 3.54 | 3.84 | 2.04 | 2.43 |
| Operating Cash Flow Coverage Ratio | 84.34 | 59.89 | 65.65 | 1.48 | 1.01 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.27 | 0.25 | 0.14 | 0.16 |
| Free Cash Flow Yield | 9.91% | 9.30% | 14.69% | 8.04% | 12.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 36.06 | 49.00 | -59.32 | -23.48 | -14.34 |
| Price-to-Sales (P/S) Ratio | 1.46 | 2.05 | 1.25 | 0.87 | 0.78 |
| Price-to-Book (P/B) Ratio | -161.60 | -141.20 | -55.51 | 17.40 | 7.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.09 | 10.75 | 6.81 | 12.43 | 8.23 |
| Price-to-Operating Cash Flow Ratio | 5.83 | 7.71 | 5.04 | 6.35 | 4.85 |
| Price-to-Earnings Growth (PEG) Ratio | 2.88 | -0.15 | 2.39 | 0.86 | 0.05 |
| Enterprise Value Multiple | 16.71 | 9.04 | 6.32 | 7.00 | 11.92 |
| Enterprise Value | 1.79B | 2.17B | 1.21B | 677.73M | 665.69M |
| EV to EBITDA | 16.71 | 9.04 | 6.32 | 7.00 | 11.92 |
| EV to Sales | 1.33 | 1.89 | 1.19 | 0.88 | 0.93 |
| EV to Free Cash Flow | 9.22 | 9.90 | 6.48 | 12.61 | 9.85 |
| EV to Operating Cash Flow | 5.33 | 7.10 | 4.79 | 6.44 | 5.80 |
| Tangible Book Value Per Share | -2.27 | -1.46 | -1.28 | -1.74 | -1.87 |
| Shareholders’ Equity Per Share | -0.04 | -0.06 | -0.08 | 0.13 | 0.26 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.33 | 0.31 | 0.24 | 0.30 | 0.30 |
| Revenue Per Share | 4.45 | 3.83 | 3.37 | 2.56 | 2.39 |
| Net Income Per Share | 0.18 | 0.16 | -0.07 | -0.09 | -0.13 |
| Tax Burden | 0.67 | 0.69 | 0.76 | 0.70 | 0.70 |
| Interest Burden | 1.65 | 0.37 | -0.44 | -1.23 | -3.71 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.85 | 0.04 | 0.08 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.04 | 6.25 | -11.78 | -3.70 | -2.96 |
Currency in AUD

